Constant | −5.013 | — |
|
Factors considered for algorithm | | |
|
Age group, years, reference group ≤60 years | | |
61–80 | 0.192 (0.076) | 0.01 |
|
BMI, kg/m2, reference group 18.5–<25 kg/m2 | | |
Underweight: <18.5 kg/m2 | 0.597 (0.179) | 0.001 |
Overweight: 25– <30 kg/m2 | −0.210 (0.087) | 0.02 |
Obese: ≥30 kg/m2 | −0.103 (0.083) | 0.21 |
|
Smoking status, reference group non-smoker | | |
Current smoker | 0.251 (0.089) | 0.005 |
Ex-smoker | 0.093 (0.078) | 0.24 |
|
Blood eosinophil counts, reference group ≤400/µl | | |
>400/µl | 0.237 (0.084) | 0.005 |
|
Rhinitis diagnosis and/or drugs | −0.212 (0.068) | 0.002 |
|
Diabetes diagnosis and/or therapy | 0.378 (0.071) | <0.001 |
|
IHD diagnosis | 0.243 (0.116) | 0.036 |
|
Anxiety and/or depression | 0.192 (0.068) | 0.005 |
|
History of anaphylaxis | 0.790 (0.275) | 0.004 |
|
GINA management step, reference group step 1–2 | | |
No therapy | 0.568 (0.121) | <0.001 |
Step 3 | 0.101 (0.108) | 0.35 |
Step 4–5 | 0.461 (0.078) | <0.001 |
|
GP consultations for LRTIs | | |
1 | 0.313 (0.086) | <0.001 |
≥2 | 0.206 (0.122) | 0.09 |
|
Acute oral steroids | | |
1 | 0.551 (0.095) | <0.001 |
2 | 0.975 (0.120) | <0.001 |
≥3 | 1.141 (0.107) | <0.001 |
|
Paracetamol | 0.204 (0.071) | 0.004 |
|
Hospitalisation, HES data | | |
≥1 | 1.877 (0.105) | <0.001 |